115 related articles for article (PubMed ID: 16295656)
1. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Adamec J; Dolezal R; Kaustová J
Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
3. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
[TBL] [Abstract][Full Text] [Related]
7. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
[TBL] [Abstract][Full Text] [Related]
8. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
9. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
10. A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2004; 49(3):265-8. PubMed ID: 15259766
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
15. Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study.
Pytela O; Klimešová V
Chem Pharm Bull (Tokyo); 2011; 59(2):179-84. PubMed ID: 21297296
[TBL] [Abstract][Full Text] [Related]
16. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
17. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
18. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
19. New S-benzylisothiosemicarbazones with antimycobacterial activity.
Petrlíková E; Waisser K; Heinisch L; Stolaříková J
Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
[TBL] [Abstract][Full Text] [Related]
20. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]